← Leaderboards
Xiang Li
University Of Houston
$2,226,657
Attributed
$2,226,657
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $447.1K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,226,657 · 1
By mechanism
R01$2,226,657 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Houston
Same institution · by research overlap
- Sai Sudha Koka$1,920,625
- Rebecca E Lee$10,463,249
Others in their field
Other Emerging Leaders on “7-Ketocholesterol”
- Matthew Sean O'Connor · Underdog Pharmaceuticals, Inc.$126,066
- Alexandra Stolzing · Underdog Pharmaceuticals, Inc.$126,066
Research focus
7-KetocholesterolAcid SphingomyelinaseAbbreviationsApplications GrantsArterial StiffnessArteriesAtherosclerosisAdhesionsBlood VesselsCardiovascular Risk FactorCardiovascular SystemCarotid ArteriesCasp1 GeneCell MembraneCellsCeramidesCeramide Signaling PathwayDefectDiabetes MellitusDna MethylationDna Modification MethylasesEndothelial CellsEndothelial DysfunctionEndothelial Stem Cell
Grant awards (5)
Enhancer of zeste homolog 2-mediated epigenetic activation of acid sphingomyelinase in endothelial dysfunction during obesity$438,177
R01 · FY2024 · HL · contact PI
Enhancer of zeste homolog 2-mediated epigenetic activation of acid sphingomyelinase in endothelial dysfunction during obesity$447,120
R01 · FY2023 · HL · contact PI
Enhancer of zeste homolog 2-mediated epigenetic activation of acid sphingomyelinase in endothelial dysfunction during obesity$447,120
R01 · FY2022 · HL · contact PI
Enhancer of zeste homolog 2-mediated epigenetic activation of acid sphingomyelinase in endothelial dysfunction during obesity$447,120
R01 · FY2021 · HL · contact PI
Enhancer of zeste homolog 2-mediated epigenetic activation of acid sphingomyelinase in endothelial dysfunction during obesity$447,120
R01 · FY2020 · HL · contact PI